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Background: Cardiovascular disease (CVD) is the number one cause of mortality worldwide and a low
high-density lipoprotein cholesterol (HDL-C) level is an important marker of CVD risk. Garlic (Allium sativum) has
been widely used in the clinic for treatment of CVD and regulation of lipid metabolism. This study investigated the
effects of a high hydrostatic pressure extract of garlic (HEG) on HDL-C level and regulation of hepatic
apolipoprotein A-I (apoA-I) gene expression.
Methods: Male Sprague–Dawley rats were divided into two groups and maintained on a high-fat control diet
(CON) or high-fat control diet supplemented with high hydrostatic pressure extract of garlic (HEG) for 5 weeks.
Changes in the expression of genes related to HDL-C metabolism were analyzed in liver, together with biometric
and blood parameters.
Results: In the HEG group, the plasma triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) levels were
significantly decreased in comparison with the CON group (P < 0.05). Dietary HEG also lowered the hepatic TG and
total cholesterol (TC) levels compared to the CON group. While the plasma HDL-C level and mRNA level of hepatic
apoA-I, which is one of primarily proteins of HDL-C particle, were significantly increased in the HEG group
compared to the CON group (P < 0.05). The gene expression of ATP-binding cassette transporter A1 (ABCA1) and
lecithin:cholesterol acyltransferase (LCAT), importantly involved in the biogenesis in HDL, were also up-regulated
by dietary HEG.
Conclusions: These results suggest that HEG ameliorates plasma lipid profiles and attenuates hepatic lipid
accumulation in the high-fat fed rats. Our findings provides that the effects of HEG on the increase of the plasma
HDL-C level was at least partially mediated by up-regulation of hepatic genes expression such as apoA-I, ABCA1,
and LCAT in rats fed a high-fat diet.
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Table 1 Effect of dietary HEG supplementation on
physiological variables
Variables CON HEG
Initial body weight (g) 107.43± 1.52 108.04 ± 1.51
Final body weight (g) 321.40± 6.25 319.25 ± 8.63
Food intake (g/day) 17.58 ± 0.41 17.56 ± 0.61
Energy intake (kcal/day) 81.64 ± 1.91 80.29 ± 2.78
Energy efficiency ratio (EER)1) 0.74 ± 0.00 0.74 ± 0.00
Liver weight 3.01 ± 0.06 3.08 ± 0.07
(g/100 g body weight)
Epididymal adipose tissue weight 1.24 ± 0.05 1.28 ± 0.07
(g/100 g body weight)
Values are expressed as mean± SEM; n = 10 for each treatment group.
1) Energy efficiency ratio (EER)=Body weight gain (g/day)/Energy intake (kcal/day).
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Cardiovascular disease (CVD) is one of the major causes
of mortality globally, and the number of deaths caused by
CVD has been increased at an alarming rate [1]. Dyslipi-
demia, which includes high levels of blood total choles-
terol (TC), low-density lipoprotein cholesterol (LDL-C),
and triglyceride (TG), and low level of high-density lipo-
protein cholesterol (HDL-C), is considered one of the
major risk factors of CVD. Guidelines for the prevention
of CVD have focused on decreasing LDL-C levels [2].
However, a substantial proportion of patients with CVD
do not have elevated LDL-C levels [3] and the role of
other lipoproteins, including HDL, in the progression of
CVD and atherosclerosis has been recently investigated
[3]. Several epidemiologic studies have reported clinical
healthful benefits associated with raising HDL-C level
and prevention of CVD [4-7]. Therefore, regulation of
HDL-C level should be one of the main goals in the treat-
ment of atherogenic dyslipidemia and reduction of the
risk of CVD. Apolipoprotein A-I (apoA-I) is a major
structural protein constituent in HDL particles, and plays
an important role in regulating HDL biosynthesis [8].
Also, ATP-binding cassette transporter A1 (ABCA1) and
lecithin:cholesterol acyltransferase (LCAT) directly con-
tributes to HDL biogenesis [9].
Garlic (Allium sativum) is one of the most well-known
herbal medicines worldwide and there has been increasing
interest in using garlic as a cholesterol-lowering agent.
However, the effect of garlic consumption on HDL-C level
remains controversial and many studies have reported con-
flicting results regarding this relationship [10-12]. The
major components of garlic are water, carbohydrates, pro-
teins, fat, dietary fiber, and essential amino acids. It also
contains high levels of saponins, vitamins, minerals, and
various biologically active sulfur compounds such as alliin,
allicin, ajoene, diallyl disulfide, allyl methanethiosulfinate,
diallyltrisulfide, and S- allylcysteine [13,14]. However, these
bioactive compounds of garlic are affected by processing
methods; thus, the processing technique may be the main
reason for the differences in the reported efficacy of vari-
ous garlic preparations.
High hydrostatic pressure processing (HPP) is a method
used to reduce microbial counts, and has been shown to
affect enzyme activity and food product functionality since
covalent bonds are not affected by pressure [15]. Thus,
HPP may only minimally modify the nutritional value and
sensory quality of fruits and vegetables. A recent study
reported that HPP affected the content, category and in-
tensity of the volatile compounds in garlic by decreasing
the alliinase activity, which influenced the formation of al-
licin [16]. Furthermore, the effects of HPP on the total
polyphenols, total flavonoid, antioxidant activities, and 5-
hydroxymethyl-2-furaldehyde (5-HMF) contents in garlic
were previously examined [17]. The objective of this studywas to elucidate the antidyslipidemic effect of the high
hydrostatic pressure extract of garlic (HEG), produced by
HPP, in rats fed a high-fat diet. This effect could be
explained by alteration of the expression of genes that is
involved in cholesterol metabolism. We hypothesized that
HEG may increase concentration of blood HDL-C level
via induction of genes expression, related with HDL bio-
genesis, such as apoA-I, ABCA1, and LCAT in rats fed a
high-fat diet.
Results
Body weight and energy intake
Rats were assigned randomly to two experimental
groups and the initial body weight of the rats was not
significantly different between the two groups (Table 1).
Final body weight was also not significantly different be-
tween the CON and HEG groups (Figure 1A; Table 1).
There were no significant differences in the amount of
energy intake and energy efficiency ratio between groups
over the experimental period (Table 1).
Liver weight and plasma AST and ALT activities
At the doses given, HEG did not cause a rise in plasma
AST and ALT activities when compared with those of
CON group (Table 2). In addition, the liver weight
(Table 1) was unaffected by HEG treatment. These data
indicate that the HEG was well tolerated by the rats
(Table 2).
Plasma lipid profiles
The HEG group had significantly lower plasma concentra-
tions of TG and LDL-C by 19% and 24%, respectively, in
comparison with the CON group (Table 2). The athero-
genic index (AI) and the ratio of LDL-C to HDL-C, which
are all significant risk factors of CVD, were also signifi-
cantly decreased by 45% and 24%, respectively, in the
HEG group as compared to the CON group (Table 2).
Figure 1 Effects of HEG supplementation on (A) body weight
and (B) food intake. Body weight and food intake were measured
twice a week. Values are expressed as mean± SEM (n = 10).
Table 2 Effects of dietary HEG supplementation on
plasma and hepatic lipid profiles
CON HEG
Plasma
Total cholesterol (mg/dl) 70.26 ± 2.31 68.57 ± 4.60
LDL cholesterol (mg/dl) 34.97 ± 2.76 26.49 ± 3.40*
HDL cholesterol (mg/dl) 25.42 ± 1.21 40.35 ± 6.30*
Triglyceride (mg/dl) 50.37 ± 3.51 40.64 ± 3.94*
LDL-C/HDL-C 2.60 ± 1.20 1.97 ± 0.26*
HDL-C/TC 0.37 ± 0.02 0.53 ± 0.05*
Atherogenic Index 1.75 ± 0.12 0.97 ± 0.18*
AST (IU/L) 65.45 ± 8.29 45.07 ± 3.98*
ALT (IU/L) 9.07 ± 0.79 10.69 ± 1.37
Hepatic lipids
Triglyceride (mg/g liver) 6.46 ± 0.65 4.18 ± 0.68*
Total cholesterol (mg/g liver) 1.70 ± 0.09 0.97 ± 0.11*
Values are expressed as mean± SEM; n = 10 for each treatment group.
*: Significantly different from the CON group at P< 0.05 by Student’s t-test.
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were significantly increased by 59% and 43%, respectively,
in the HEG group relative to the CON group in rats fed a
high-fat diet (Table 2).
Hepatic lipid profiles
The contents of hepatic TG and TC were investigated to
evaluate the effects of HEG on the reduction of hepatic
lipids levels. The amounts of hepatic TC and TG were sig-
nificantly reduced by 43% and 35%, respectively, in the
HEG group as compared to the CON group (Table 2).
These results support the hypothesis that HEG may regu-
late TG and TC levels in rats fed a high-fat diet.
Gene expressions of hepatic apoA-1, ABCA1, and LCAT
ApoA-I is one of major structural protein constituents
in HDL particle and alteration of the hepatic apoA-I
gene expression affects blood apoA-I concentration.Thus, we investigated the effect of HEG supplementa-
tion on the mRNA level of apoA-I. Our data showed
that the hepatic apoA-I mRNA level was 1.6- fold higher
in the HEG group than in the CON group (P < 0.05)
(Figure 2A). The mRNA levels of hepatic ABCA1 and
LCAT, which are importantly involved in the HDL bio-
genesis, were also significantly increased by 1.5- fold
(P < 0.05) and 1.8- fold (P < 0.01), respectively, in the
HEG group as compared as the CON group (Figure 2B, C)
in high-fat fed rats.
Discussion
We investigated the effects of HEG on the regulation of
lipid profiles in rats fed a high-fat diet. The antilipidemic
effects of garlic have been previously reported [18-20].
Our results showed that dietary HEG reduced hepatic TC
and TG levels. Previous studies have reported that garlic
reduces hepatic cholesterol and TG levels [21-23]. The
hypocholesterolemic effects of the garlic extract stem oc-
curred in part from the inhibition of hepatic cholesterol
synthesis by water-soluble sulfur compounds, such as S-
allylcysteine and ajoene [22]. Reduction of hepatic choles-
terol may also be due to inhibition of cholesterol biosyn-
thesis or activation of reverse cholesterol transport (RCT),
which extracts cholesterol. Also, in vivo and in vitro stud-
ies have indicated that garlic and its constituents inhibit
pivotal enzymes involved in the biosynthesis of choles-
terol, such as HMG-CoA reductase [9,18,22].
In the present study, treatment with HEG reduced
plasma TG concentration in rats fed a high-fat diet. This
observation is in agreement with human [23,24] and ani-
mal [18] studies, which showed an inverse association be-
tween dietary garlic and the concentration of plasma TG.
Figure 2 Effects of HEG supplementation on the hepatic apoA-I
(A), ABCA1 (B), and LCAT (C) mRNA levels. Total RNA extracted
from the liver was used for mRNA expression analysis by real-time
PCR. Bars are expressed as mean± SEM (n = 10). * P< 0.05 and **
P< 0.01 versus the CON group.
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shown that garlic has beneficial effects on reducing the ac-
cumulation of TG in blood. These effects were suggested
with activation of liver phosphatidate phosphohydrolase
(PAP) and fatty acid synthease (FAS), which play a critical
role in controlling the biosynthesis of TG [21,25,26].
Dietary HEG increased plasma HDL-C concentration
and decreased plasma LDL-C concentration. The pri-
mary function of HDL is to remove cholesterol from
peripheral cells and transport cholesterol to the liver for
biliary excretion by RCT. In addition, HDL has been
shown to prevent foam cell formation, thus retarding
the progress of atherosclerosis [27]. Therefore, the
present results clearly demonstrated that supplementa-
tion of HEG favorably modified cholesterol metabolism.
Our findings were in agreement with other studies,
which reported that garlic consumption increased HDL-
C level in hyperlipidemic individuals [10], animals [11],
and patients with coronary artery disease [28]. The LDL-
C/HDL-C ratio and HDL-C/TC ratio are important indi-
cators of CVD and atherosclerosis [29]. In this study, the
HDL-C/TC ratio was higher and the LDL-C/HDL-C
ratio was lower in the HEG group relative to the CON
group. When garlic powder was added into the diet at a
concentration of 1%, plasma TC and LDL-C levels were
decreased and HDL-C level were increased in rabbits
[30], resulting in a decrease in the LDL-C/HDL-C ratio.
Hence, our observations indicate that dietary HEG may
have hypolipidemic effects by reducing the TC and TG
levels in the body and CVD protection effects by regu-
lating the HDL-C/TC and LDL-C/HDL-C ratios.
ApoA-I is a main protein component of HDL particles
and constitutes about 70% of the apolipoprotein content
of HDL particles [31], and is thought to be a better pre-
dictor of CVD risk than TC and LDL-C [32]. ApoA-I
acts as a cofactor for LCAT, which is a key enzyme
involved in removing excess cholesterol from tissues and
incorporating it into the HDL [33]. Hence, plasma
apoA-I concentration is correlated with plasma HDL-C
concentration, and apoA-I mRNA level may be an im-
portant determinant of blood HDL-C concentration
[34,35]. However, less is known about the effect of garlic
on the HDL-C and the expression of genes associated
with HDL-C metabolism.
Treatment with HEG increased the apoA-I mRNA
level, which corresponded to an increase in the HDL-C
level. Dorfman et al. [36] reported that treatment with
dietary fatty acids, such as coconut oil and butter,
resulted in an increase in both the blood HDL-C level
and apoA-I concentrations, and these effects were found
to be associated with the expression of apoA-I gene in
animal studies. They indicate that regulation of apoA-I
gene expression may be associated with the regulation of
HDL-C level. Therefore, we suggest cautiously that









Mineral Mix1) 42.68 42.68
Vitamin Mix2) 12.20 12.20
Choline Bitartrate 3.05 3.05
High hydrostatic pressure extract of garlic3) - 20.00
Fat% (calories) 45 45
Total 1000 1000
1) AIN-93 G mineral mixture.
2) AIN-93 G vitamin mixture.
3) The amount of corn starch in control diet (CON) was adjusted accordingly
when the dietary high hydrostatic pressure extract of garlic (HEG) was added.
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level with up-regulation of the apoA-I gene expression.
Previous studies have shown that garlic consumption
produces hypolipidemic effects without changing the
blood HDL-C level [37]. Furthermore, although the
apoA-I mRNA level is associated with HDL-C level,
the increased level of HDL-C is not always caused by
the change of hepatic apoA-I mRNA level. Choi et al. [38]
reported that soy pinitol supplementation increased plasma
HDL-C and apoA-I concentrations, whereas the expression
of the hepatic apoA-I gene was not affected by soy pinitol.
However, in our study, HEG supplementation was shown
to increase the plasma HDL-C concentration with up-
regulation of apoA-I gene expression.
ApoA-I plays a pivotal role in RCT by functioning as
an acceptor of cellular phospholipids and cholesterol
and as an activator of LCAT. Recent studies indicated
that the functional interactions of apoA-I with ABCA1
is necessary for the initial lipidation of apoA-I [9].
ABCA1 facilitates the efflux of cellular phospholipids
and cholesterol to extracellular lipid-poor apoA-I, and
lapidated apoA-I produces discoidal preβ-HDL particles.
Thus, interaction between apoA-I and ABCA1 is an es-
sential step for formation of HDL that ultimately deter-
mines plasma HDL-C level. The preβ-HDL particles are
subsequently transformed into mature spherical HDL
particles by LCAT, which is an enzyme that concerts free
cholesterol into cholesteryl ester and is critical for the
maintenance and maturation of HDL metabolism [9]. In
this study, we have showed that the expressions of hep-
atic ABCA1 and LCAT were increased by HEG
supplementation.
Conclusions
In conclusion, HEG ameliorated plasma lipid profiles by
decreasing the LDL-C level and increasing the HDL-C
level in high-fat fed rats. Also dietary supplementation
with HEG attenuated hepatic lipid accumulation by re-
ducing the contents of TG and TC. This study provides
that the effects of HEG on the increase of the plasma
HDL-C level was at least partially mediated by up-
regulation of genes related with HDL biogenesis, such as
apoA-I, ABCA1, and LCAT. Accordingly, the antidyslipi-
demic effects of HEG imply that HEG has potential as a
bioactive food ingredient for the prevention of CVD in
rats fed a high-fat diet.
Methods
Materials
High hydrostatic pressure extract of garlic (HEG) was pro-
vided as a gift from the Korea Food Research Institute
(Seongnam, Gyeonggi, Korea). The dietary HEG powder
used in this study was prepared as follows: Cloves of fresh
garlic were purchased from the local market (Seosan,Chungnam, Korea). 550 g of the fresh garlic was crushed
with 450 ml of distilled water and digested with the fol-
lowing enzymes: Viscozyme L, Celluclast 1.5 L, and Liquo-
zyme supra (Novo Nordisk, Bagsvaerd, Denmark). The
garlic slurry was adjusted to pH 5.5 and processed under
100 MPa for a 24 hr at 50°C using a high hydrostatic pres-
sure machine TFS-2 L (Toyo Koatsu Co. Ltd., Hiroshima,
Japan) to solubilize the garlic cell wall and to obtain the
major component such as allicin and water soluble materi-
als. The HEG contained 1.24 mg/g of allicin, which was
higher than hot water extract of garlic (0.86 mg/g) as
determined by high performance liquid chromatography.
The hot water extract of garlic was prepared from the
grounded garlic boiled in 100°C hot water for 1 hr. All
other chemicals were of the highest pure grade available.
Animals and diets
Four–week–old male Sprague–Dawley (SD) rats (G-bio
company, Gyeonggi, Korea), weighing 60 ~ 70 g, were in-
dividually housed in temperature-controlled room
(22 ± 2°C) under 12 hr light/dark conditions. Rats con-
sumed a commercial chow diet (Zeigler Bros Inc., PA,
USA) and water ad libitum for a week to stabilize their
metabolic condition. After acclimatization, the rats were
completely randomized into two groups of ten rats each
and maintained on one of the following diets: a high-fat
control diet (CON) or a high-fat control diet supplemen-
ted with 2% (w/w) high hydrostatic pressure extract of
garlic (HEG) for 5 weeks. To induce hyperlipidemia in
the rats, they were maintained on a high-fat control diet
(45% of total energy as fat) based on the AIN-93 G diet
with slight modifications [39] (Table 3). The amount of
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the dietary HEG powder was added (Table 3). Food in-
take and body weight were measured twice a week dur-
ing the treatment period (Monday, Thursday). The
average weekly body weight and daily food intake of two
groups were calculated. At the end of the experiment,
the rats were deprived of food overnight and anesthe-
tized with intramuscular injection of Zoletil/Rompun
(Bayer, Leverkusen, Germany) mixture (4:1) at a dose of
0.1 ml/ 80 g body weight. A central longitudinal incision
was made in the abdominal wall and blood samples were
collected by cardiac puncture. Blood samples were cen-
trifuged at 2800 × g for 20 min at 4°C to obtain plasma,
which was then stored at −20°C for biochemical ana-
lyses. The liver was harvested, frozen immediately in li-
quid nitrogen, and stored in −70°C. All experimental
protocols were approved by The Ewha Womans Univer-
sity Animal Experimentation Ethics Committee for the
care and use of laboratory animals.
Plasma biochemical measurements
The plasma levels of TG, TC, HDL-C, AST and ALT
were determined by the enzymatic colorimetric methods
[40] using commercial kits (Asan Pharm Co., Ltd., Seoul,
Korea). The Atherogenic Index (AI) was calculated using
the formula of Rosenfeld [41]. In addition, the ratio of
HDL-C to TC was calculated.
AI ¼ TC−HDL−cholesterolð Þ=HDL−cholesterol
Hepatic and fecal lipids analysis
Hepatic and fecal lipids were extracted using the method
described by Bligh and Dyer [42]. TC and TG were
determined by enzymatic colorimetric methods using
commercial kits as described above.
Real-time qRT-PCR
Total RNA was isolated from liver tissue using the Trizol
reagent (Invitrogen, Carlsbud, CA, USA). The corre-
sponding cDNA was synthesized from 4 μg of total RNA
using M-MLV reverse transcriptase. After cDNA synthe-
sis, real-time qPCR was performed using universal SYBR
Green PCR Master Mix on a fluorometric thermal cycler
(Rotor-Gene 2000, Corbett Research, Mortlake, Austra-
lia). Primers were designed using an online program
(Primer3; http://frodo.wi.mit.edu/) [43]. The sequences
of the sense and antisense primers used for amplification
were as follows: apoA-I, 50-CTGGGTTCAACTGT
TGGTCG-30 and 50-GGGCTGCATCTTCTGTTTCA-
30; ABCA1, 50- CCCAATCCCAAACACTCCTT-30 and
50-TCTTCATCGTCCAGTTCCCA-30; LCAT, 50- TAA
CAATGGGTATGTGCGGG-30 and 50-GCCAAGGCTG
TGTCCAATAA-30; β-actin, 50-GGCACCACACTTTCTACAAT-30 and 50-AGGTCTCAAACATGATCTGG-30.
The delta delta Ct method was used for relative quantifi-
cation [44]. The delta Ct value for each sample was
determined by calculating the difference between the Ct
value of the target gene and the Ct value of the β-actin
reference gene. The normalized level of expression of
the target gene in each sample was calculated using the
formula 2-ΔΔCt. Values were expressed as fold change
over the control.
Statistical analysis
The effects of HEG on the plasma lipid concentrations
and hepatic lipid contents were analyzed. All data are
presented as mean ± standard error of mean (SEM, n =
number of rats). The statistical significances of the dif-
ference between the means of the two groups of samples
(CON and HEG) were analyzed using Student’s t-test.
Statistical analyses were performed using the SAS soft-
ware version 9.2 (SAS Inc., NC, USA). P < 0.05 and
P < 0.01 were taken to indicate a significant difference.
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